Krance RA - Search Results

1

Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.

Friend BD, Muhsen IN, Patel S, Hill LC, Lulla P, Ramos CA, Pingali SR, Kamble RT, John TD, Salem B, Bhar S, Doherty EE, Craddock J, Sasa G, Wu M, Wang T, Martinez C, Krance RA, Heslop HE, Carrum G. Friend BD, et al. Among authors: krance ra. Bone Marrow Transplant. 2022 Apr;57(4):579-585. doi: 10.1038/s41409-022-01599-5. Epub 2022 Feb 1. Bone Marrow Transplant. 2022. PMID: 35105965

2

Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study.

Phipps S, Brenner M, Heslop H, Krance R, Jayawardene D, Mulhern R. Phipps S, et al. Bone Marrow Transplant. 1995 Jun;15(6):829-35. Bone Marrow Transplant. 1995. PMID: 7581077

3

Gene transfer and bone marrow transplantation.

Brenner MK, Heslop HE, Rill D, Li C, Nilson T, Roberts M, Smith C, Krance R, Rooney C. Brenner MK, et al. Cold Spring Harb Symp Quant Biol. 1994;59:691-7. doi: 10.1101/sqb.1994.059.01.080. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587132 No abstract available.

4

Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.

Brenner M, Krance R, Heslop HE, Santana V, Ihle J, Ribeiro R, Roberts WM, Mahmoud H, Boyett J, Moen RC, et al. Brenner M, et al. Hum Gene Ther. 1994 Apr;5(4):481-99. doi: 10.1089/hum.1994.5.4-481. Hum Gene Ther. 1994. PMID: 8049305 No abstract available.

5

Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors.

Krance R, Heslop HE, Mahmoud H, Ribeiro R, Douglass E, Hurwitz C, Santana V, Kun L, Horowitz MM, Brenner MK. Krance R, et al. Bone Marrow Transplant. 1993 Jan;11(1):33-6. Bone Marrow Transplant. 1993. PMID: 8431709 Clinical Trial.

6

Transfer of marker genes into hemopoietic progenitor cells.

Brenner MK, Heslop HE, Rill D, Li C, Smith C, Krance R, Rooney C. Brenner MK, et al. Cytokines Mol Ther. 1996 Sep;2(3):193-200. Cytokines Mol Ther. 1996. PMID: 9384704 Review.

7

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Heslop H, et al. Hum Gene Ther. 2000 Jul 1;11(10):1465-75. doi: 10.1089/10430340050057530. Hum Gene Ther. 2000. PMID: 10910143 Clinical Trial. No abstract available.

8

Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector.

Brenner MK, Heslop H, Krance R, Horowitz M, Strother D, Nuchtern J, Grilley B, Martingano E, Cooper K. Brenner MK, et al. Hum Gene Ther. 2000 Jul 1;11(10):1477-88. doi: 10.1089/10430340050057549. Hum Gene Ther. 2000. PMID: 10910144 Clinical Trial. No abstract available.

9

Tacrolimus clearance is age-dependent within the pediatric population.

Przepiorka D, Blamble D, Hilsenbeck S, Danielson M, Krance R, Chan KW. Przepiorka D, et al. Bone Marrow Transplant. 2000 Sep;26(6):601-5. doi: 10.1038/sj.bmt.1702588. Bone Marrow Transplant. 2000. PMID: 11041564 Clinical Trial.

10

Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey.

Hsu B, May R, Carrum G, Krance R, Przepiorka D. Hsu B, et al. Bone Marrow Transplant. 2001 Nov;28(10):945-50. doi: 10.1038/sj.bmt.1703269. Bone Marrow Transplant. 2001. PMID: 11753549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page